eIF4E mRNA-cap-competitive covalent inhibitors (Celgene)

N/A

Report date: 2025/03/20 14:58:42
NME

Base Information

Drug NameeIF4E mRNA-cap-competitive covalent inhibitors (Celgene)
Drug Alias Nameeukaryotic initiation factor 4E inhibitors (Celgene)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic translation initiation factor 4E inhibitors
TargetsEukaryotic translation initiation factor 4E
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesCelgene Corp
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A